fundsforNGOs - Grants and Resources for Sustainability

Grants and Resources for Sustainability

  • Subscribe for Free
  • Premium Sign in
  • Premium Sign up
  • Home
  • Latest Funds
    • Agriculture, Food and Nutrition
    • Animals and Wildlife
    • Arts and Culture
    • Children
    • Civil Society Development
    • Community Development
    • COVID
    • Democracy and Good Governance
    • Disability
    • Economic Development
    • Education
    • Employment and Labor
    • Environmental Conservation and Climate Change
    • Family Support
    • Healthcare
    • HIV and AIDS
    • Housing and Shelter
    • Humanitarian Relief
    • Human Rights
    • Human Service
    • Information Technology
    • LGBTQ
    • Livelihood Development
    • Media and Development
    • Narcotics, Drugs and Crime
    • Old Age Care
    • Peace and Conflict Resolution
    • Poverty Alleviation
    • Refugees and Asylum Seekers
    • Science and Technology
    • Sports and Development
    • Sustainable Development
    • Water, Sanitation and Hygiene (WASH)
    • Women and Gender
    • Youth
  • Awards
  • Conferences
  • Fellowships
  • Funds for Companies
  • Sample Proposals
  • Jobs
  • Submit Your Grant
  • About us
  • Contact
    • Advertise with us
Your are here: fundsforngos.org » Grants.gov » Indo-U.S. Vaccine Action Program to Support Research Projects

Indo-U.S. Vaccine Action Program to Support Research Projects

122
SHARES
ShareTweetWhatsappEmail

Deadline: 7 May 2019

The Department of Health and Human Services, National Institutes of Health (NIH) is inviting organizations/institutions for Vaccine Action Program (VAP) with an aim  to support collaborative vaccine-related research projects that ultimately reduce the burden of infectious diseases of importance in India, the U.S., the South Asian region and globally.

The program will conduct vaccine-related research through U.S.-Indo collaborations on a variety of infectious diseases, including immunologic characterization.

Priorities

  • Discovery, demonstration of the proof of principle, development of novel manufacturing processes, evaluation of the safety and efficacy and demonstration of the effectiveness of the use of new and improved vaccines to prevent:
    • HIV/AIDS
    • Tuberculosis
    • Pandemic and interpandemic influenza
    • Dengue and Dengue Hemorrhagic Fever (DHF)
    • Malaria
    • Enteric diseases
  • Discovery and/or development of vaccine adjuvants promoting mucosal or systemic responses; analysis of their mechanism of action; optimization of vaccine adjuvants to increase efficacy while reducing reactogenicity; development of in vitro assays for evaluating adjuvanticity and/or reactogenicity; identification of correlates of adjuvanticity;
  • Characterization of local and/or systemic immune responses and regulatory mechanisms in infants, compared to older children or adults, to vaccines or natural exposure/illness due to infectious diseases;
  • Mechanisms of systemic or mucosal immune response across the lifespan to infection or vaccination, including characterization of mucosal vaccine immune responses, and correlates/surrogates of mucosal immune responses;
  • New manufacturing and vaccine delivery technology;
  • Effectiveness of the introduction of new and improved vaccines into public health immunization programs;
  • Epidemiology of infectious disease in the human population.

Please visit next page for information regarding eligibility criteria and the application procedure.

Next>>

RSS Q&A

  • How to Get Core Funding?
  • How to research ideas before writing the Concept Note?
  • What should one keep in mind while managing NGO finances?
  • How Marketing and Communication Strategies can help NGOs achieve Fundraising Success?
  • How to establish Effective Governance in Your NGO?
  • What do funders look for in a grantee?
  • What to do if your grant proposal is rejected?
  • What are the challenges and problems in writing proposals for raising funds for my NGO?
  • What steps do NGOs need to follow to remain sustainable?
  • How can NGOs ensure that they achieve programmatic sustainability?
  • What type of Project Titles Could impress a Donor?
  • What are the types of Scams NGOs should be aware of?
  • How NGOs can identify Genuine Grant Opportunities and Donor Organizations and avoid Scams?
  • Why is financial management important for NGOs
  • What are the core values one should follow when establishing an NGO?
  • How NGOs can develop a quick Proposal Concept Note to apply for Grants to address the COVID-19 impact?
  • How to get started with Twitter?
  • How to set up 501(c) 3 non-profit in United States and what are its advantages?
  • How to Impress a Donor?
  • What career options are there in International NGOs?

Free Resources for NGOs

Premium Proposal Writing Resources

  • How can Short Concept Notes attract Large Funding
  • Things to Know When Applying for USAID Grants
  • 2020 Guide on How to Write Proposals
  • How to Prepare Your Proposal in under 60 Minutes
  • How can Sample Proposals help you write the Perfect Grant Proposal
  • A Simple Guide on How to Submit a Funding Request to Bill and Melinda Gates Foundation
  • Sample Proposal Templates that can Succeed!
  • How to Write Proposals under Tight Deadlines
  • How to submit an Unsolicited Proposal to USAID
  • Things to know when applying for the European Commission Grants
  • Golden Tips for Writing Proposals from Top Donor Agencies
  • Simplifying Logframes: A Guide for NGOs on How to Develop a Logical Framework

Terms of Use
Third-Party Links & Ads
Disclaimers
Copyright Policy
General
Privacy Policy

Contact us
Submit a Grant
Advertise, Guest Posting & Backlinks
Fight Fraud against NGOs
About us

Premium Sign in
Premium Sign up
Secret Discount Link
Premium Customer Support
Premium Terms of Service

FUNDSFORNGOS LLC
140 Broadway 46th Floor
New York, NY 10005
United States

https://fundsforngos.org | https://fundsforngospremium.com

SUBSCRIBE FOR FREE!

Click here to Get Email Alerts about the Latest Grants
We promise never to spam, sell or share your information.

Go to mobile version